Monocyte cell
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 16, 2010
Issued Date -
N/A
app pub date -
Jul 31, 2007
filing date -
Aug 1, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to human and mouse monocyte cells expressing Tie2 and CD14 or CD16 and their use in methods for regulating angiogenesis and vascular integrity, such as methods of inducing angiogenesis, promoting vessel growth or stabilization, treating pathological disorders, inhibiting angiogenesis, and diagnosing or monitoring a pathological disorder.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully